The FT’s Innovation editor John Thornhill and San Francisco tech correspondent Hannah Murphy have in the past both met and interviewed Pavel Durov, the secretive founder of Telegram who was arrested in France for alleged failure to address criminality on the messaging app. In the first episode of a two-part series, they discuss how Durov went from free speech hero to a wanted man, and what the charges against him mean for the future of Telegram – and Big Tech – and the limits of free speech. Does his arrest flag a turning point in the regulation of social media platforms? Want more?Pavel Durov, Telegram’s self-mythologising founderHow Telegram chief Pavel Durov miscalculated on moderationEmmanuel Macron hits back at claims Telegram chief’s arrest is politicalThe Durov case is not about free speechRussian lawmakers hit back at arrest of Telegram chief Pavel Durov in FranceThis episode of Tech Tonic is presented by John Thornhill and Hannah Murphy. The producer is Persis Love. Edwin Lane is senior producer. The executive producer is Manuela Saragosa. Sound engineering by Breen Turner. The FT’s head of audio is Cheryl Brumley.Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare